Log in

Relevant bibliographies by topics / Therapeutics / Journal articles

To see the other types of publications on this topic, follow the link: Therapeutics.

Journal articles on the topic 'Therapeutics'

Author: Grafiati

Published: 4 June 2021

Last updated: 30 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Therapeutics.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Misselbrook, David. "Therapeutics?" British Journal of General Practice 71, no. 713 (November 25, 2021): 553. http://dx.doi.org/10.3399/bjgp21x717845.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Azimi, A., S. Kuznecovs, J. Kuznecovs, A. Blazejczyk, M. Switalska, S. Chlopicki, A. Marcinek, et al. "Therapeutics." Annals of Oncology 23, suppl 5 (June 1, 2012): v23—v32. http://dx.doi.org/10.1093/annonc/mds162.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Joyce, David A., and Kenneth F. Ilett. "Therapeutics." Medical Journal of Australia 161, no. 10 (November 1994): 622–26. http://dx.doi.org/10.5694/j.1326-5377.1994.tb127645.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Zipursky, Robert. "THERAPEUTICS." Schizophrenia Research 153 (April 2014): S65. http://dx.doi.org/10.1016/s0920-9964(14)70209-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Van Zeeland, Yvonne R. A. "Therapeutics." Veterinary Clinics of North America: Exotic Animal Practice 21, no. 2 (May 2018): i. http://dx.doi.org/10.1016/s1094-9194(18)30020-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

van Zeeland, Yvonne R. A. "Therapeutics." Veterinary Clinics of North America: Exotic Animal Practice 21, no. 2 (May 2018): xiii—xv. http://dx.doi.org/10.1016/j.cvex.2018.02.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Alisi, Anna, Sara Tomaselli, Clara Balsano, and Angela Gallo. "Hepatitis C virus therapeutics: Editing enzymes promising therapeutic targets?" Hepatology 54, no. 2 (July 25, 2011): 742. http://dx.doi.org/10.1002/hep.24409.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Barish, Robert A., and Jerome F. X. Naradzay. "Ophthalmologic Therapeutics." Emergency Medicine Clinics of North America 13, no. 3 (August 1995): 649–67. http://dx.doi.org/10.1016/s0733-8627(20)30611-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Greish, Khaled, Jun Fang, Takao Inutsuka, Akinori Nagamitsu, and Hiroshi Maeda. "Macromolecular Therapeutics." Clinical Pharmacokinetics 42, no. 13 (2003): 1089–105. http://dx.doi.org/10.2165/00003088-200342130-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Katsarou, Angeliki, and Kostas Pantopoulos. "Hepcidin Therapeutics." Pharmaceuticals 11, no. 4 (November 21, 2018): 127. http://dx.doi.org/10.3390/ph11040127.

Full text

Abstract:

Hepcidin is a key hormonal regulator of systemic iron homeostasis and its expression is induced by iron or inflammatory stimuli. Genetic defects in iron signaling to hepcidin lead to “hepcidinopathies” ranging from hereditary hemochromatosis to iron-refractory iron deficiency anemia, which are disorders caused by hepcidin deficiency or excess, respectively. Moreover, dysregulation of hepcidin is a pathogenic cofactor in iron-loading anemias with ineffective erythropoiesis and in anemia of inflammation. Experiments with preclinical animal models provided evidence that restoration of appropriate hepcidin levels can be used for the treatment of these conditions. This fueled the rapidly growing field of hepcidin therapeutics. Several hepcidin agonists and antagonists, as well as inducers and inhibitors of hepcidin expression have been identified to date. Some of them were further developed and are currently being evaluated in clinical trials. This review summarizes the state of the art.

APA, Harvard, Vancouver, ISO, and other styles

11

Cheng, Juei-Tang, I.-Min Liu, and Szu-Chuan Shen. "Plant Therapeutics." Plants 11, no. 20 (October 14, 2022): 2720. http://dx.doi.org/10.3390/plants11202720.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Yang, Priscilla L. "Antiviral Therapeutics." ACS Infectious Diseases 7, no. 6 (June 1, 2021): 1297. http://dx.doi.org/10.1021/acsinfecdis.1c00271.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Shafer, Steven L., and Richard Simoneaux. "Omicron Therapeutics." ASA Monitor 86, no. 2 (February 1, 2022): 21–37. http://dx.doi.org/10.1097/01.asm.0000820396.70292.ef.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Tong, Rong, David A. Christian, Li Tang, Horacio Cabral, James R. Baker, Kazunori Kataoka, Dennis E. Discher, and Jianjun Cheng. "Nanopolymeric Therapeutics." MRS Bulletin 34, no. 6 (June 2009): 422–31. http://dx.doi.org/10.1557/mrs2009.118.

Full text

Abstract:

AbstractPolymers have been extensively utilized in the design of nanometer-sized delivery vehicles of chemotherapeutics for clinical cancer therapy. Polymeric nanoparticulate delivery vehicles, with chemotherapeutics being either conjugated or encapsulated, have been developed into a variety of different architectures, including polymer-drug conjugates with linear or branched polymers, micelles, and polymersomes. This review describes the progress that has been made in the field of polymeric nanomedicine that brings the science closer to clinical realization of nanopolymeric therapeutics for its application in cancer treatment.

APA, Harvard, Vancouver, ISO, and other styles

15

Ritter, J. M. "Experimental Therapeutics." British Journal of Clinical Pharmacology 57, no. 3 (March 2004): 354. http://dx.doi.org/10.1111/j.1365-2125.2003.02031.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Fletcher, Liz. "Mojave Therapeutics." Nature Biotechnology 20, S6 (June 2002): BE16. http://dx.doi.org/10.1038/nbt0602supp-be16a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

van Brunt, Jennifer. "AIDS Therapeutics." Nature Biotechnology 6, no. 7 (July 1988): 767–70. http://dx.doi.org/10.1038/nbt0788-767.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Napper, Dr Genevieve, Dr Julie Albietz, and Ian Douglas. "Ocular therapeutics." Clinical and Experimental Optometry 85, no. 6 (November 2002): 397–98. http://dx.doi.org/10.1111/j.1444-0938.2002.tb02393.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Napper, Genevieve, Julie Albietz, and Ian Douglas. "Ocular therapeutics." Clinical and Experimental Optometry 86, no. 1 (January 2003): 63–64. http://dx.doi.org/10.1111/j.1444-0938.2003.tb03060.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Albietz, Dr Julie, and Ian Douglas. "Ocular therapeutics." Clinical and Experimental Optometry 86, no. 2 (March 2003): 131–32. http://dx.doi.org/10.1111/j.1444-0938.2003.tb03072.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Napper, Dr Genevieve, Ian Douglas, and Dr Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 87, no. 1 (January 2004): 42–43. http://dx.doi.org/10.1111/j.1444-0938.2004.tb03146.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 88, no. 6 (November 2005): 428–29. http://dx.doi.org/10.1111/j.1444-0938.2005.tb05112.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 88, no. 1 (January 2005): 60–61. http://dx.doi.org/10.1111/j.1444-0938.2005.tb06667.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 88, no. 2 (March 2005): 119–20. http://dx.doi.org/10.1111/j.1444-0938.2005.tb06681.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 88, no. 3 (May 2005): 188–89. http://dx.doi.org/10.1111/j.1444-0938.2005.tb06694.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 88, no. 4 (July 2005): 259–60. http://dx.doi.org/10.1111/j.1444-0938.2005.tb06706.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 88, no. 5 (September 2005): 354–55. http://dx.doi.org/10.1111/j.1444-0938.2005.tb06721.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 89, no. 1 (January 2006): 45–46. http://dx.doi.org/10.1111/j.1444-0938.2006.00011.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 89, no. 3 (May 2006): 188–89. http://dx.doi.org/10.1111/j.1444-0938.2006.00035.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Albietz, Julie, Ian Douglas, and Genevieve Napper. "Ocular therapeutics." Clinical and Experimental Optometry 89, no. 4 (July 2006): 261–62. http://dx.doi.org/10.1111/j.1444-0938.2006.00053.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 89, no. 5 (September 2006): 334–35. http://dx.doi.org/10.1111/j.1444-0938.2006.00078.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 89, no. 6 (November 2006): 396–97. http://dx.doi.org/10.1111/j.1444-0938.2006.00095.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 90, no. 1 (January 2007): 57–58. http://dx.doi.org/10.1111/j.1444-0938.2007.00118.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Albietz, Julie, Ian Douglas, and Genevieve Napper. "Ocular therapeutics." Clinical and Experimental Optometry 90, no. 2 (March 2007): 141–42. http://dx.doi.org/10.1111/j.1444-0938.2007.00126.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 90, no. 3 (May 2007): 212–13. http://dx.doi.org/10.1111/j.1444-0938.2007.00144.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Albietz, Julie, Ian Douglas, and Genevieve Napper. "Ocular therapeutics." Clinical and Experimental Optometry 90, no. 4 (July 2007): 303. http://dx.doi.org/10.1111/j.1444-0938.2007.00165.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Albietz, Julie, Ian Douglas, and Genevieve Napper. "Ocular therapeutics." Clinical and Experimental Optometry 90, no. 5 (September 2007): 386–87. http://dx.doi.org/10.1111/j.1444-0938.2007.00182.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Napper, Genevieve, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 90, no. 6 (November 2007): 474. http://dx.doi.org/10.1111/j.1444-0938.2007.00200.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Albietz, Julie, and Genevieve Napper. "Ocular therapeutics." Clinical and Experimental Optometry 91, no. 1 (January 2008): 120–21. http://dx.doi.org/10.1111/j.1444-0938.2007.00238.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Napper, Genevieve, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 91, no. 2 (March 2008): 193–94. http://dx.doi.org/10.1111/j.1444-0938.2008.00251.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Albietz, Julie, and Genevieve Napper. "Ocular therapeutics." Clinical and Experimental Optometry 91, no. 3 (May 2008): 322–23. http://dx.doi.org/10.1111/j.1444-0938.2008.00266.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Albietz, Julie, and Genevieve Napper. "Ocular therapeutics." Clinical and Experimental Optometry 91, no. 5 (September 2008): 480–81. http://dx.doi.org/10.1111/j.1444-0938.2008.00317.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Napper, Genevieve, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 91, no. 6 (November 2008): 565. http://dx.doi.org/10.1111/j.1444-0938.2008.00329.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Marks, Steven L., and Joseph Taboada. "Transdermal Therapeutics." Journal of the American Animal Hospital Association 39, no. 1 (January 1, 2003): 19–21. http://dx.doi.org/10.5326/0390019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Bentley, Stephen, and Mohammed Sebaihia. "Bacterial therapeutics." Nature Reviews Microbiology 5, no. 3 (March 2007): 170–71. http://dx.doi.org/10.1038/nrmicro1633.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Pattison, Richard. "Thermal therapeutics." Nature Methods 14, no. 1 (January 2017): 13. http://dx.doi.org/10.1038/nmeth.4139.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Wackett, Lawrence P. "Microbial therapeutics." Microbial Biotechnology 10, no. 3 (April 25, 2017): 666–67. http://dx.doi.org/10.1111/1751-7915.12724.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

&NA;. "NP Therapeutics." Nurse Practitioner 22, no. 9 (September 1997): 138???143. http://dx.doi.org/10.1097/00006205-199709000-00029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

&NA;. "NP Therapeutics." Nurse Practitioner 22, no. 10 (October 1997): 129???136. http://dx.doi.org/10.1097/00006205-199710000-00041.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

&NA;. "NP Therapeutics." Nurse Practitioner 22, no. 12 (December 1997): 94???99. http://dx.doi.org/10.1097/00006205-199712000-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!